Welcome to our dedicated page for FendX Technologies news (Ticker: FDXTF), a resource for investors and traders seeking the latest updates and insights on FendX Technologies stock.
About FendX Technologies Inc.
FendX Technologies Inc. (OTCQB: FDXTF) is a Canada-based nanotechnology company dedicated to creating innovative solutions to enhance public health and safety by reducing the spread of pathogens. The company specializes in developing advanced surface protection coatings designed to minimize contamination on high-touch surfaces across various industries. Leveraging cutting-edge nanotechnology, FendX aims to provide scalable, effective, and sustainable solutions to address critical challenges in infection prevention and control.
Core Products and Technologies
FendX's flagship product, REPELWRAP™ film, is a revolutionary protective surface coating film that utilizes award-winning nanotechnology to repel pathogens, including bacteria and viruses, by over 98%. This innovative film prevents adhesion and reduces transmission on surfaces prone to contamination, making it ideal for healthcare settings, hospitality venues, transportation hubs, and other high-traffic environments. Additionally, the company is developing a bifunctional spray coating that not only repels pathogens but also kills them, offering a versatile solution for various applications.
Research and Development
Research and development are at the heart of FendX's operations. The company collaborates with industry-leading partners, including McMaster University, to advance its nanotechnology. FendX holds exclusive worldwide licenses for its proprietary technology and intellectual property portfolio, encompassing both film and spray coating formulations. This strategic partnership ensures that FendX remains at the forefront of innovation in the nanotechnology space.
Strategic Partnerships and Market Position
FendX has established key collaborations with global industry leaders such as Dunmore International Corp. to optimize and scale the manufacturing of its products. These partnerships enable the company to conduct pilot manufacturing runs and real-world testing across diverse environments, including healthcare facilities, restaurants, fitness centers, and entertainment venues. By working with strategic testing partners, FendX ensures its products meet rigorous performance standards under real-world conditions.
Intellectual Property and Global Reach
FendX is committed to building a robust intellectual property portfolio to protect its groundbreaking technologies. The company has secured patents in multiple jurisdictions, including the United States, Japan, China, and Europe, for its REPELWRAP™ film and related nanotechnology. This global IP strategy underscores FendX's dedication to maintaining a competitive edge in the market while expanding its international presence.
Applications and Market Potential
The company's products have broad applications across various sectors, including healthcare, hospitality, transportation, and public venues. By addressing the critical need for infection prevention, FendX's technologies offer significant value to industries seeking to enhance safety and hygiene standards. The company's ongoing efforts to commercialize its products through licensing and distribution agreements further position it as a key player in the nanotechnology market.
Commitment to Innovation and Collaboration
FendX continuously explores new opportunities to expand its product pipeline and enhance its market offerings. Recent initiatives include the development of AI-enhanced pathogen detection technology and the acquisition of intellectual property related to open-cell foam-based cleaning solutions. These advancements align with the company's mission to provide innovative, disruptive technologies that make people's lives safer.
Conclusion
FendX Technologies Inc. is a pioneering force in the field of nanotechnology, offering cutting-edge solutions to combat pathogen transmission. With a strong focus on R&D, strategic partnerships, and intellectual property protection, the company is well-positioned to meet the growing demand for advanced surface protection products. By leveraging its expertise and innovative technologies, FendX continues to make significant strides toward creating a safer and healthier world.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D), a nanotechnology company developing surface protection coatings, has announced the grant of stock options and restricted share units (RSUs) to certain directors, officers, employees, and consultants. The company granted 3,950,000 stock options at an exercise price of $0.29, expiring in five years, with a vesting schedule of 50% on the grant date and 25% each at nine and eighteen months. Additionally, 1,150,000 RSUs were granted to two officers and a consultant, following the same vesting schedule. These grants are in accordance with the company's equity incentive plan dated October 19, 2021, and are subject to a four-month and one-day hold period from the grant date.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) has announced plans to conduct real-world testing of its REPELWRAP™ film with LA Fitness at their Vaughan location near Toronto, Ontario. This marks the sixth testing site for FendX's nanotechnology surface protection coating. The company is collaborating with Dunmore International Inc. for pilot manufacturing runs of REPELWRAP™ film.
The testing at LA Fitness will involve applying the film to high-touch surfaces over approximately four weeks to assess its repelling capabilities, as previously demonstrated in McMaster University's lab. This partnership with LA Fitness, a well-established gym chain with 690+ locations across North America, aims to provide valuable insights into the film's performance in a high-traffic environment.
FendX Technologies Inc. (CSE: FNDX, OTCQB: FDXTF) responded to a request from OTC Markets Group Inc. regarding recent promotional activities related to its common shares. On June 18, 2024, OTC Markets highlighted promotional content distributed by Spartan Trading Inc., an affiliate of Spark Newswire Inc., which FendX had engaged for investor relations and digital marketing services since May 9, 2024. FendX reviewed and commented on this content, which included factual statements about the company. FendX stated it is unaware of any unusual trading activity resulting from this promotion. Furthermore, FendX confirmed that neither its management nor the consultants have engaged in significant trading of the company’s securities in the past 90 days, except for Spartan, which transacted 55,000 shares. FendX reiterated that it is an early-stage issuer with growth objectives yet to be realized and advised investors to review its continuous disclosure filings for comprehensive risk disclosures.
FendX Technologies, a nanotechnology company specializing in surface protection coatings, has released a corporate update highlighting key milestones and future plans. CEO Dr. Carolyn Myers reported significant advancements in the development and commercialization of the company's REPELWRAP™ film. The automation of the manufacturing process is being optimized through pilot runs, with commercial production expected to begin by the end of 2024. Testing sites for the film include various high-traffic locations such as restaurants and care facilities. The company also announced progress in its medical catheter nano-coating project, which aims to reduce bacterial biofilms and blood clots, and a new spray nanotechnology formulation that's more scalable. Additionally, FendX raised over $2.86M through private placements and warrant exercises. The company continues to build its intellectual property portfolio and seeks further growth through partnerships and acquisitions. Future goals include completing the scale-up of REPELWRAP™, finalizing the spray formulation, and starting proof-of-concept studies for the catheter project.
FendX Technologies announced the initiation of real-world testing for its REPELWRAP™ film with New Vista Society, a non-profit dedicated to senior care and affordable housing. The film, designed for surface protection using nanotechnology, will undergo tests at New Vista's Burnaby, BC facility. The testing will include the application of REPELWRAP™ to high-touch surfaces to observe its repellent performance over four weeks. This marks FendX's fifth testing site, following successful pilot manufacturing runs with Dunmore International.
FendX Technologies announced that its nanotechnology product, REPELWRAP™ film, will be featured at the Infection Prevention and Control Canada (IPAC) conference on June 11, 2024. The company's post-doctoral fellow, Dr. Sara Moetakef Imani, will present on the film's capabilities in repelling drug-resistant bacteria and viruses, emphasizing its scalability and potential for enhancing safety in high-touch environments. The IPAC Canada conference provides a platform for highlighting advancements in infection control and public health safety. The film is currently in pilot manufacturing at Dunmore International Corp. for intermediate size real-world testing.
FendX Technologies, a nanotechnology company focused on surface protection coatings to reduce pathogen spread, has started trading on Germany's Tradegate Exchange under the ticker symbol 'E8D'.
This move aims to broaden its investor base and offer European investors easier access to its shares with low transaction costs. Dr. Carolyn Myers, President and CEO, expressed excitement about this development, which complements FendX's existing listings on the Frankfurt Stock Exchange.
Tradegate Exchange, 60% owned by Deutsche Börse AG, is a fully regulated platform facilitating the trading of over 10,000 securities globally.
FendX Technologies announced plans to conduct real-world testing of its REPELWRAP™ film with Draganfly, a leading drone solutions developer. This collaboration aims to test the film's repelling properties by covering parcel delivery boxes on Draganfly's heavy-lift drones exposed to environmental stresses. Testing results aim to confirm the film's performance, as previously seen in lab settings. Other testing sites include Giulietta, Island View Place Care, and El Mocambo. These diverse environments are expected to contribute valuable insights for the product's final design.
FendX Technologies will present its nanotechnology advancements at the 107th Canadian Chemistry Conference and Exhibition (CSC 2024) in Winnipeg, Manitoba, on June 6, 2024. Professor Tohid Didar from McMaster University will discuss FendX's REPELWRAP™ film and spray nanotechnology in a talk titled 'Nano-engineered interfaces for diagnostics, therapeutics, and infection control.' This event showcases Canadian chemistry research and innovation, providing a platform for FendX to highlight its progress in developing surface protection coatings for high-touch areas prone to contamination.
FendX Technologies announced a new development opportunity for its spray nanotechnology in collaboration with McMaster University. The technology combines surface protection with AI and colorimetric sensors to detect bacterial contamination. This formulation can achieve over 96% reliability in identifying bacteria on surfaces through a color change. The development is covered under existing agreements and requires no additional research funding. Dr. Carolyn Myers, CEO, highlighted the potential of this technology to complement existing projects and contribute to their goal of mitigating the spread of lethal pathogens.
FAQ
What is the current stock price of FendX Technologies (FDXTF)?
What is the market cap of FendX Technologies (FDXTF)?
What does FendX Technologies Inc. specialize in?
What is REPELWRAP™ film?
Who are FendX's key collaborators?
What industries can benefit from FendX's products?
How does FendX protect its intellectual property?
What other products is FendX developing?
How does FendX ensure the effectiveness of its products?
What is FendX's approach to commercialization?
